Adient price target lowered to $23 from $29 at UBS
bullish
Public signal · 1-minute delayed
Source-backed market context you can read and share without an account.
bullish
What happened, with direct paths to the underlying reporting
UBS cut Adient's target to 23 from 29, but the target remains above the current price of 17.51, indicating upside potential.
Target: $23
Posted price: $17.51
Analyst firm: UBS
Transparent limits for an AI-generated research aid
StockNews.AI groups source reporting, classifies the event, and measures subsequent price movement. This is informational research, not investment advice. Prices may be delayed or unavailable.